Castro, J.I.; Araujo-Rodríguez, D.G.; Valencia-Llano, C.H.; López Tenorio, D.; Saavedra, M.; Zapata, P.A.; Grande-Tovar, C.D.
Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics 2025, 17, 1113.
https://doi.org/10.3390/pharmaceutics17091113
AMA Style
Castro JI, Araujo-Rodríguez DG, Valencia-Llano CH, López Tenorio D, Saavedra M, Zapata PA, Grande-Tovar CD.
Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics. 2025; 17(9):1113.
https://doi.org/10.3390/pharmaceutics17091113
Chicago/Turabian Style
Castro, Jorge Iván, Daniela G. Araujo-Rodríguez, Carlos Humberto Valencia-Llano, Diego López Tenorio, Marcela Saavedra, Paula A. Zapata, and Carlos David Grande-Tovar.
2025. "Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196" Pharmaceutics 17, no. 9: 1113.
https://doi.org/10.3390/pharmaceutics17091113
APA Style
Castro, J. I., Araujo-Rodríguez, D. G., Valencia-Llano, C. H., López Tenorio, D., Saavedra, M., Zapata, P. A., & Grande-Tovar, C. D.
(2025). Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics, 17(9), 1113.
https://doi.org/10.3390/pharmaceutics17091113
